2019
DOI: 10.1007/s12072-019-09980-1
|View full text |Cite
|
Sign up to set email alerts
|

Correction to: Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update

Abstract: The article Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update, written by [Shiv Sarin], was originally published electronically on the publisher’s internet portal (currently SpringerLink) on June 06, 2019 without open access.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
45
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(45 citation statements)
references
References 0 publications
0
45
0
Order By: Relevance
“…In addition, the accuracy of the new model to predict 90-day mortality rate was compared with the MELD score. The inclusion criteria for the patients were in accordance with the Asian Pacific Association for HBV-ACLF, 9 which was detailed as follows: (a) age not lower than 16 years; (b) hepatitis B virus surface antigen (HBsAg) positivity for at least 6 months; (c) serum bilirubin ≥5 mg/dL (≥85 µmol/L) with a sudden exacerbation of liver disease; (d) international normalized ratio (INR) >1.5; and (e) hepatic encephalopathy (HE) and/or ascites within 28 days. The exclusion standards were as follows: (a) pregnancy or lactation; (b) co-infection with human immunodeficiency virus; (c) severe comorbidities, e.g., previous renal failure, carcinoma, cardiac dysfunctions, etc; (d) other hepatic disorders, like hepatitis A, C or E, autoimmune hepatitis, alcohol consumption, or hereditary liver diseases; or (e) infections that required hospitalization.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, the accuracy of the new model to predict 90-day mortality rate was compared with the MELD score. The inclusion criteria for the patients were in accordance with the Asian Pacific Association for HBV-ACLF, 9 which was detailed as follows: (a) age not lower than 16 years; (b) hepatitis B virus surface antigen (HBsAg) positivity for at least 6 months; (c) serum bilirubin ≥5 mg/dL (≥85 µmol/L) with a sudden exacerbation of liver disease; (d) international normalized ratio (INR) >1.5; and (e) hepatic encephalopathy (HE) and/or ascites within 28 days. The exclusion standards were as follows: (a) pregnancy or lactation; (b) co-infection with human immunodeficiency virus; (c) severe comorbidities, e.g., previous renal failure, carcinoma, cardiac dysfunctions, etc; (d) other hepatic disorders, like hepatitis A, C or E, autoimmune hepatitis, alcohol consumption, or hereditary liver diseases; or (e) infections that required hospitalization.…”
Section: Introductionmentioning
confidence: 99%
“…The enrolment criteria for these patients corresponded to the Asian Pacific Association for ACLF. 10 The inclusion criteria were as follows: (a) patients who were at least 16 years-old; (b) patients who were HBV surface antigen (HBsAg)-positive for at least 6 months; (c) patients with a total bilirubin (TBIL) of >171 µmol/L and a sudden exacerbation of liver disease; (d) patients with an international normalized ratio (INR) of >1.5; (e) patients who had ascites within 4 weeks and/or had an onset of hepatic encephalopathy (HE). The exclusion criteria were as follows: (a) pregnant or lactating patients; (b) patients co-infected with human immunodeficiency virus; (c) patients with severe diseases, such as heart dysfunction, previous renal failure, cancer, etc.…”
Section: Methodsmentioning
confidence: 99%
“…In addition, based on an institutional decision, intra‐ and interdepartmental pediatric patients with a suspicion of CLD at the level of the consultant were referred to the above pediatric unit. The exclusion criteria for enrollment were presence of hepatic decompensation, pediatric acute liver failure (PALF), 4 or acute‐on‐chronic liver failure (ACLF) 5 at any time during the illness duration or course of hospital stay.…”
Section: Methodsmentioning
confidence: 99%